DARI-OX is a scientifically engineered proprietary Optimized Dopamine Reuptake Inhibitor Xtract with high selectivity for the dopamine transporter (DAT) and a ratio of selectivity to noradrenaline (NET) and serotonin transporters (SERT) very similar to classical DARI reference standards.
Research Indications: Vigilance/Focus, ADHD, Parkinson's
4 Item Items
In Stock
Warning: Last items in stock!
Availability date:
DARI-OX Optimized Dopamine Reuptake Inhibitor Xtract
DARI-OX is a scientifically engineered proprietary Optimized Dopamine Reuptake Inhibitor Xtract with high selectivity for the dopamine transporter (DAT) and a ratio of selectivity to noradrenaline (NET) and serotonin transporters (SERT) very similar to classical DARI reference standards.
Research Indications: Vigilance/Focus, ADHD, Parkinson's
Recipient :
* Required fields
or Cancel
DARI-OX is a scientifically engineered proprietary Optimized Dopamine Reuptake Inhibitor Xtract with high selectivity for the dopamine transporter (DAT) and a ratio of selectivity to noradrenaline (NET) and serotonin transporters (SERT) very similar to classical DARI reference standards.
Research Indications: Vigilance/Focus, ADHD, Parkinson's
Animal in vivo Data:
DARI-OX expressed an EC50 of DAT inhibition at 20mg/kg p.o. and 4mg/kg intranasal in mice.
Future Human Trials Protocols and Projects:
Dose arms for sublingal administration protocols are projected to be 20mg, 40mg, 80mg for expressing high efficacy, high therapeutic index dopaminergic effects. Sublingual ROA enhances potency ~4-fold over oral ROA.
Format of Supply:
Optimized solution in water/ethanol/glycerine 50/25/25.
USAGE: For Research Use Only! Not For Use in Humans.